FASN and glioblastoma: Crocetin treatment suppresses fatty acid synthase (FASN) expression in glioblastoma cell lines (U251, U87MG, U373 and U138), activating apoptosis pathways, as evidenced by the presence of cleaved caspase-3 bands [157].